Skip to main navigation Skip to search Skip to main content

Risk and characteristics of tuberculosis after anti-tumor necrosis factor therapy for inflammatory bowel disease: a hospital-based cohort study from Korea

Press/Media

Period28 Oct 2021

Media coverage

1

Media coverage